Literature DB >> 21602480

Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland.

Pankaj Kumar Agarwal1, David C Mansfield, Dorothy Mechan, Rustam Al-Shahi Salman, Richard J Davenport, Myles Connor, Richard Metcalfe, Richard Petty.   

Abstract

INTRODUCTION: Oculopharyngeal muscular dystrophy (OPMD) presents with progressive ptosis, dysphagia and limb girdle weakness, and is caused by expansion of a trinucleotide tandem repeat within the gene encoding poly-(A) binding protein 2. AIM: To review the clinical manifestations of all genetically confirmed patients with OPMD in Scotland identified since 2002, and to estimate the delay between symptom onset and diagnosis. Method Retrospective case note review.
RESULTS: The authors identified 17 patients. The commonest first symptom was ptosis at about the age of 60 years. Three to 20 years elapsed from the onset of ptosis to OPMD diagnosis. In 14 (82%) patients, dysphagia had developed by the time of diagnosis, and four (24%) out of these 14 patients with dysphagia had undergone a decade of investigation and treatment for pharyngeal problems. Thirteen patients (77%) also had symptoms of limb girdle muscle weakness. Every patient had a first-degree relative with ptosis.
CONCLUSIONS: OPMD could have been diagnosed earlier in every patient in this case series. Greater awareness of OPMD among ophthalmologists, gastroenterologists and otolaryngologists may lead to earlier diagnosis, improved management and avoidance of unnecessary investigations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602480     DOI: 10.1136/bjo.2010.200378

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Neglected conditions: Oculopharyngeal muscular dystrophy.

Authors:  Michel J Belliveau; Martin W ten Hove
Journal:  CMAJ       Date:  2014-04-01       Impact factor: 8.262

2.  Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.

Authors:  Fanny Roth; Jamila Dhiab; Alexis Boulinguiez; Hadidja-Rose Mouigni; Saskia Lassche; Elisa Negroni; Laura Muraine; Alix Marhic; Alison Oliver; Jeanne Lainé; Andrée Rouche; Erin K O'Ferrall; Baziel van Engelen; Coen Ottenheijm; Hagar Greif; Sergiu Blumen; Jean Lacau St Guily; Sophie Perie; Gillian Butler-Browne; Vincent Mouly; Capucine Trollet
Journal:  Acta Neuropathol       Date:  2022-10-05       Impact factor: 15.887

3.  Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.

Authors:  Pascale Richard; Capucine Trollet; Tanya Stojkovic; Alix de Becdelievre; Sophie Perie; Jean Pouget; Bruno Eymard
Journal:  Neurology       Date:  2016-12-23       Impact factor: 9.910

4.  PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.

Authors:  Pascale Richard; Capucine Trollet; Teresa Gidaro; Laurence Demay; Guy Brochier; Edoardo Malfatti; Fernando Ms Tom; Michel Fardeau; Pascal Lafor; Norma Romero; Marie-Laure Martin-N; Guilhem Sol; Xavier Ferrer-Monasterio; Jean Lacau Saint-Guily; Bruno Eymard
Journal:  J Neuromuscul Dis       Date:  2015-06-04

5.  Common pre-diagnostic features in individuals with different rare diseases represent a key for diagnostic support with computerized pattern recognition?

Authors:  Lorenz Grigull; Sandra Mehmecke; Ann-Katrin Rother; Susanne Blöß; Christian Klemann; Ulrike Schumacher; Urs Mücke; Xiaowei Kortum; Werner Lechner; Frank Klawonn
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

6.  Diagnostic support for selected neuromuscular diseases using answer-pattern recognition and data mining techniques: a proof of concept multicenter prospective trial.

Authors:  Lorenz Grigull; Werner Lechner; Susanne Petri; Katja Kollewe; Reinhard Dengler; Sandra Mehmecke; Ulrike Schumacher; Thomas Lücke; Christiane Schneider-Gold; Cornelia Köhler; Anne-Katrin Güttsches; Xiaowei Kortum; Frank Klawonn
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-08       Impact factor: 2.796

7.  Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools.

Authors:  Rick H de Leeuw; Dominique Garnier; Rosemarie M J M Kroon; Corinne G C Horlings; Emile de Meijer; Henk Buermans; Baziel G M van Engelen; Peter de Knijff; Vered Raz
Journal:  Eur J Hum Genet       Date:  2018-11-19       Impact factor: 4.246

Review 8.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

9.  Longitudinal Assessment of Strength, Functional Capacity, Oropharyngeal Function, and Quality of Life in Oculopharyngeal Muscular Dystrophy.

Authors:  Rosemarie H M J M Kroon; Johanna G Kalf; Bert J M de Swart; Barbara M van der Sluijs; Jeffrey C Glennon; Vered Raz; Baziel G van Engelen; Corinne G C Horlings
Journal:  Neurology       Date:  2021-08-11       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.